From TokenPost · · 40s
CMS Fraud Rule Excludes Life Sciences
CMS proposed Medicare fraud rule omits life sciences and diagnostics firms.
In brief
CMS proposed Medicare fraud rule omits life sciences and diagnostics firms. CMS proposed rule excludes life sciences and diagnostics companies from Medicare fraud oversight. Originally reported by TokenPost.
CMS Fraud Rule Proposal

The Centers for Medicare & Medicaid Services did not mention life sciences or diagnostic companies in its proposed Medicare and Medicaid fraud rule.
Rule Covers Other Programs
The rule covers Medicare, Medicaid, CHIP and the Health Insurance Marketplace, with fraud focus on Medicare and Medicaid.
Proposed Changes Remain Draft
Proposed Medicare Advantage risk-adjustment audit changes are not final and the rule does not establish policy for life sciences or diagnostics.
The big picture
CMS proposed rule excludes life sciences and diagnostics companies from Medicare fraud oversight.
Read the TL;DR — this story on one card.





